GILD Obtains Positive CHMP Opinion for Liver Disease Drug
The CHMP recommends the approval of Gilead's seladelpar in combination with ursodeoxycholic acid for the treatment of primary ...
Zacks.com on MSN8h
CHMP Endorses Merck's Kidney Cancer Drug for Two Indications
The CHMP's opinion is based on positive results from two late-stage studies on MRK's Welireg in two indications associated ...
Pharmabiz17h
EMA’s human medicine committee recommends marketing approval for acoramidis for treatment of transthyretin amyloid cardiomyopathy
EMA’s human medicine committee recommends marketing approval for acoramidis for treatment of transthyretin amyloid cardiomyopathy: Berlin Monday, December 16, 2024, 13:00 Hrs [I ...
PharmaTimes12h
CSL receives positive opinion for garadacimab in hereditary angioedema
Global biotechnology leader CSL has announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for ...
GSK’s ViiV Healthcare says the CHMP of EMA issued positive opinion for Vocabria
GSK (GSK) announced that ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer (PFE) and Shionogi as ...
PharmTech10h
Several Orphan Drugs Among Medicines Recommended for Approval by EMA in December
EMA recommended 17 drugs for marketing authorization in December, including treatments for rare heart conditions, anemia, and liver disease.
Acoramidis Receives Positive CHMP Opinion for Treatment of Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
The Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of acoramidis in the EU based on positive results from the ...
emjreviews.com10h
Lilly gains EU backing for drug to treat Crohn’s disease
The drug has received a nod from the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP).
Daily1d
Gilead Sciences Seladelpar gets positive CHMP opinion for Primary Biliary Cholangitis
Gilead Sciences, Inc. has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines ...
Pharmabiz15h
EMA’s CHMP committee recommends approval of Biocon Biologics’ Yesintek
EMA’s CHMP committee recommends approval of Biocon Biologics’ Yesintek: Our Bureau, Bengaluru Monday, December 16, 2024, 14:30 Hrs [IST] Biocon Biologics (BBL), a fully integr ...